Horizon Kinetics Medical ETF Rating $28.94 +0.26 (+0.92%) Closing price 08/22/2025 11:32 AM EasternExtended Trading$28.80 -0.14 (-0.48%) As of 08/22/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.64Holdings in MEDX have an aggregate rating of Moderate Buy based on 348 analyst ratings issued in the past year covering 23 companies (81.1% of the portfolio).MEDX Aggregate Price Target$28.94High Prediction$28.94Average Prediction$28.94Low Prediction$28.94Holdings in MEDX have an aggregate price target of $28.94 and a range of $28.94 to $28.94 covering 23 companies (81.1% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.29%LLYEli Lilly and Company$710.73+0.1%4.9993 of 5 stars2.65$950.17 33.7%23Trending NewsAnalyst Upgrade9.43%ABBVAbbVie$210.28+0.4%4.7652 of 5 stars2.96$214.95 2.2%27Trending News6.66%ALNYAlnylam Pharmaceuticals$454.38-2.8%4.172 of 5 stars2.85$405.33 -10.8%26News CoverageInsider Trade5.28%AZNAstraZeneca$80.97+0.6%2.9587 of 5 stars2.80$86.00 6.2%5Positive News5.09%JNJJohnson & Johnson$179.10+0.1%4.8782 of 5 stars2.65$176.29 -1.6%20Trending NewsAnalyst Forecast4.69%BMYBristol Myers Squibb$47.84-1.2%4.7839 of 5 stars2.24$56.38 17.8%21Trending News4.15%AMGNAmgen$293.72-0.7%4.7072 of 5 stars2.33$303.76 3.4%21Trending NewsInsider Trade3.88%PFEPfizer$25.83+0.3%4.6761 of 5 stars2.39$28.12 8.9%18Trending News3.78%ALKSAlkermes$29.75+2.4%4.7348 of 5 stars2.83$41.08 38.1%12Trending NewsAnalyst Revision3.65%CRSPCRISPR Therapeutics$54.32+2.8%3.7933 of 5 stars2.50$71.60 31.8%163.33%MRKMerck & Co., Inc.$87.18+1.3%4.9866 of 5 stars2.35$107.44 23.2%20Positive News3.16%IONSIonis Pharmaceuticals$42.69-1.3%4.6464 of 5 stars2.86$60.85 42.5%14Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.61%GSKGSK$40.15+0.2%2.8543 of 5 stars1.88$37.38 -6.9%8Trending NewsAnalyst Revision2.49%REGNRegeneron Pharmaceuticals$589.48-1.5%4.8544 of 5 stars2.81$829.65 40.7%26Positive NewsDividend Announcement2.46%BIIBBiogen$139.31+0.1%4.8462 of 5 stars2.34$185.74 33.3%32News CoveragePositive News1.27%GALTGalectin Therapeutics$4.10+5.7%2.4064 of 5 stars3.00$6.00 46.3%11.06%BEAMBeam Therapeutics$16.64+3.9%2.2363 of 5 stars3.07$48.45 191.2%141.02%NTLAIntellia Therapeutics$10.52+3.8%4.6278 of 5 stars2.58$29.05 176.2%19Insider Trade0.89%LTRNLantern Pharma$4.51+7.6%2.6618 of 5 stars3.00$25.00 454.3%10.82%HLNHaleon$9.81-0.1%4.3414 of 5 stars2.78$12.33 25.7%9News CoveragePositive News0.74%SDZNYSandoz Group$62.78+3.4%1.5082 of 5 stars2.003Gap Up0.67%VNDAVanda Pharmaceuticals$4.75+5.3%4.4116 of 5 stars3.50$16.50 247.4%2Analyst Forecast0.66%BCYCBicycle Therapeutics$7.10+0.1%3.5818 of 5 stars2.70$22.22 213.0%10News CoveragePositive NewsShort Interest ↓ This page (NASDAQ:MEDX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access